Cargando…
Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma
Dickkopf-1 (DKK1), broadly expressed by tumor cells from human multiple myeloma (MM) and other cancers but absent from most normal tissues, may be an ideal target for immunotherapy. Our previous studies have shown that DKK1 (peptide)-specific cytotoxic T lymphocytes can effectively lyse primary MM c...
Autores principales: | Li, Rong, Zheng, Chengyun, Wang, Qiang, Bi, Enguang, Yang, Maojie, Hou, Jian, Fu, Weijun, Yi, Qing, Qian, Jianfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927895/ https://www.ncbi.nlm.nih.gov/pubmed/32079700 http://dx.doi.org/10.3324/haematol.2019.236836 |
Ejemplares similares
-
DKK1 as a novel target for myeloma immunotherapy
por: Qian, Jianfei, et al.
Publicado: (2012) -
CD4(+) T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma
por: Zhang, Liang, et al.
Publicado: (2015) -
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma
por: Li, Yi, et al.
Publicado: (2015) -
Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
por: Dun, Xiaoyi, et al.
Publicado: (2010) -
Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
por: Zhang, Lu, et al.
Publicado: (2012)